- Report
- November 2025
- 120 Pages
Global
From €5285EUR$5,950USD£4,605GBP
- Report
- October 2025
- 120 Pages
Global
From €5285EUR$5,950USD£4,605GBP
- Report
- January 2026
- 193 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- January 2026
- 198 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- January 2026
- 192 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- October 2025
- 120 Pages
Global
From €5285EUR$5,950USD£4,605GBP
- Report
- March 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- March 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- March 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- May 2026
- 272 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- November 2025
- 185 Pages
Global
From €3997EUR$4,500USD£3,482GBP
- Report
- September 2025
- 137 Pages
Global
From €3552EUR$3,999USD£3,095GBP
- Report
- November 2025
- 160 Pages
Global
From €2982EUR$3,358USD£2,598GBP
€3509EUR$3,950USD£3,057GBP
- Report
- January 2026
- 82 Pages
Global
From €3500EUR$4,221USD£3,156GBP
- Report
- March 2026
- 87 Pages
Global
From €3500EUR$4,221USD£3,156GBP
- Report
- December 2025
- 120 Pages
Middle East
From €5285EUR$5,950USD£4,605GBP
- Report
- August 2023
- 267 Pages
Global
From €4693EUR$5,468USD£3,950GBP
- Report
- August 2024
- 143 Pages
Global
From €4130EUR$4,650USD£3,599GBP
- Report
- April 2023
- 131 Pages
Global
From €1999EUR$2,250USD£1,741GBP
- Report
- December 2024
- 110 Pages
Global
From €5285EUR$5,950USD£4,605GBP

The Drug Substance market is a key component of the Drug Discovery process. It involves the production of active pharmaceutical ingredients (APIs) for use in the development of new drugs. Drug Substance manufacturers are responsible for producing APIs in a variety of forms, such as powders, liquids, and tablets. The APIs are then used in the formulation of drug products, which are then tested in clinical trials.
The Drug Substance market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the APIs. The market is also highly competitive, with many companies vying for market share. Companies must also adhere to strict environmental regulations, as well as ethical standards, in order to remain competitive.
Some of the major players in the Drug Substance market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more